According to www.techsciresearch.com latest report- Global Chemotherapy Market By Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast & Opportunities, 2025. Report URL- https://www.techsciresearch.com/report/chemotherapy-market/4735.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
GLOBAL CHEMOTHERAPY MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

2. 2
Scope of Report
Product of Interest (POI): Chemotherapy
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East &
Africa
Global chemotherapy market is expected to witness double digit CAGR during the forecast period
owing to the rising prevalence of cancer cases and the growing requirement for its treatment.
Governments in various economies are investing in healthcare sector to provide patients with
better healthcare facilities, which is promoting the growth of chemotherapy market. Additionally,
pharma companies are carrying out extensive research and development activities to launch
novel treatments for cancer, which is expected to drive the growth of chemotherapy market in the
coming years. The main objective of chemotherapy treatment is to stop or prevent the growth of
cancerous cells.
Market Segmentation
DRUGS
• Alone
• Combination
• Hospitals
• Oncology Centers
• Others
END USER
TYPE
• Alkylating Agents
• Nitrosoureas
• Antimetabolites
• Anti-tumor Antibiotics
• Topoisomerase
Inhibitors
• Mitotic Inhibitors
• Corticosteroids
• Others
INDICATION
• Leukaemia
• Lymphoma
• Hodgkin Disease
• Multiple Myeloma
• Sarcoma
• Bone Marrow Disease
• Immune System
Disorder
ROUTE OF
ADMINISTRATION
• Intravenous
• Orally
• Transdermal
• Intraperitoneal
• Intrapleural
• Intrathecal
• Intravesical
• Others

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Chemotherapy Market
4. Executive Summary
5. Voice of Customer
6. Global Chemotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drugs (Alone, Combination)
6.2.2.
By Type (Alkylating Agents, Nitrosoureas, Antimetabolites, Anti-tumor Antibiotics,
Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others)
6.2.3.
By Indication (Leukaemia, Lymphoma, Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow
Disease, Immune System Disorder)
6.2.4.
By Route of Administration (Intravenous, Orally, Transdermal, Intraperitoneal, Intrapleural, Intrathecal,
Intravesical, Others)
6.2.5 By End User (Hospitals, Oncology Centers, Others)
6.2.6. By Company (2019)
6.2.7. By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)
6.3. Product Market Map

4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Chemotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drugs
7.2.2. By Type
7.2.3. By Indication
7.2.4. By Route of Administration
7.2.5. By End User
7.2.6. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Chemotherapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drugs
7.3.1.2.2. By Type
7.3.1.2.3. By Indication
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By End User

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Chemotherapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drugs
7.3.2.2.2. By Type
7.3.2.2.3. By Indication
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By End User
7.3.3. Australia Chemotherapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drugs
7.3.3.2.2. By Type
7.3.3.2.3. By Indication
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By End User
7.3.4. Japan Chemotherapy Market Outlook

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drugs
7.3.4.2.2. By Type
7.3.4.2.3. By Indication
7.3.4.2.4. By Route of Administration
7.3.4.2.5. By End User
7.3.5. South Korea Chemotherapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drugs
7.3.5.2.2. By Type
7.3.5.2.3. By Indication
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By End User
8. Europe Chemotherapy Market Outlook

7. 7
Table of Contents
S. No. Contents Page No.
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drugs
8.2.2. By Type
8.2.3. By Indication
8.2.4. By Route of Administration
8.2.5. By End User
8.2.6. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Europe: Country Analysis
8.3.1. France Chemotherapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drugs
8.3.1.2.2. By Type
8.3.1.2.3. By Indication
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By End User

8. 8
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Chemotherapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drugs
8.3.2.2.2. By Type
8.3.2.2.3. By Indication
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By End User
8.3.3. United Kingdom Chemotherapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drugs
8.3.3.2.2. By Type
8.3.3.2.3. By Indication
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By End User

9. 9
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Chemotherapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drugs
8.3.4.2.2. By Type
8.3.4.2.3. By Indication
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By End User
8.3.5. Spain Chemotherapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drugs
8.3.5.2.2. By Type
8.3.5.2.3. By Indication
8.3.5.2.4. By Route of Administration
8.3.5.2.5 By End User
9. North America Chemotherapy Market Outlook
9.1. Market Size & Forecast

10. 10
Table of Contents
S. No. Contents Page No.
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drugs
9.2.2. By Type
9.2.3. By Indication
9.2.4. By Route of Administration
9.2.5. By End User
9.2.6. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Chemotherapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drugs
9.3.1.2.2. By Type
9.3.1.2.3. By Indication
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By End User
9.3.2. Canada Chemotherapy Market Outlook

11. 11
Table of Contents
S. No. Contents Page No.
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drugs
9.3.2.2.2. By Type
9.3.2.2.3. By Indication
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By End User
9.3.3. Mexico Chemotherapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drugs
9.3.3.2.2. By Type
9.3.3.2.3. By Indication
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By End User
10. South America Chemotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast

12. 12
Table of Contents
S. No. Contents Page No.
10.2.1. By Drugs
10.2.2. By Type
10.2.3. By Indication
10.2.4 By Route of Administration
10.2.5. By End User
10.2.6. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Chemotherapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1 By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drugs
10.3.1.2.2. By Type
10.3.1.2.3. By Indication
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By End User
10.3.2. Argentina Chemotherapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drugs
10.3.2.2.2. By Type
10.3.2.2.3. By Indication

13. 13
Table of Contents
S. No. Contents Page No.
10.3.2.2.4. By Route of Administration
10.3.2.2.5. By End User
10.3.3. Colombia Chemotherapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drugs
10.3.3.2.2. By Type
10.3.3.2.3. By Indication
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By End User
11. Middle East & Africa Chemotherapy Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drugs
11.2.2. By Type
11.2.3. By Indication
11.2.4. By Route of Administration
11.2.5. By End User
11.2.6. By Country (South Africa, Saudi Arabia, UAE)
11.3. Middle East & Africa : Country Analysis

14. 14
Table of Contents
S. No. Contents Page No.
11.3.1. South Africa Chemotherapy Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drugs
11.3.1.2.2. By Type
11.3.1.2.3. By Indication
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Chemotherapy Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drugs
11.3.2.2.2. By Type
11.3.2.2.3. By Indication
11.3.2.2.4. By Route of Administration
11.3.2.2.5. By End User
11.3.3. UAE Chemotherapy Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drugs

15. 15
Table of Contents
S. No. Contents Page No.
11.3.3.2.2. By Type
11.3.3.2.3. By Indication
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
15. Strategic Recommendations
16. About Us & Disclaimer

16. RESEARCHMETHODOLOGY

17. 17
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global chemotherapy
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global chemotherapy
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

18. 18
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global chemotherapy market. The team has
market, while considering the the major influencing factors such as rising prevalence of cancer cases and the growing requirement for
forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as chemotherapy
users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 chemotherapy companies, 100 – 120 end-users, and 15 – 20 industry experts and other
chemotherapy market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking
was averaged out, to arrive at the market size data during 2015-2019.

19. 19
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by drugs, by type, by indication, by route of administration, by end user, by company and
by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to
arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
Market share by drugs, by type, by indication, by route of administration, by end user, by company and by region were calculated based on the responses received through primary
surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of chemotherapy markets. The final shares
were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global chemotherapy market, TechSci Research used
various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

20. 20
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• AstraZeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim International GmbH
• Eli Lilly and Company
• Fresenius Kabi AG
• Novartis AG
• Sanofi
• Merck & Co.
• Pfizer Inc.
• Roche Holding AG
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Tarveda Therapeutics
• Bayer AG
• Johnson & Johnson Services Inc.
• Celltrion Inc.
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

21. 21
Industry Brief
According to TechSci Research report, “Global Chemotherapy Market By Drugs (Alone, Combination), By Type (Alkylating Agents, Nitrosoureas,
Antimetabolites, Anti-tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Others), By Indication (Leukaemia, Lymphoma,
Hodgkin Disease, Multiple Myeloma, Sarcoma, Bone Marrow Disease, Immune System Disorder), By Route of Administration (Intravenous, Orally,
Transdermal, Intraperitoneal, Intrapleural, Intrathecal, Intravesical, Others), By End-User (Hospitals, Specialty Center, Others), By Region, Forecast &
Opportunities, 2025”, the global chemotherapy market is expected to witness high growth rate during the forecast period owing to increasing prevalence
of cancer around the world. Additionally, increasing funds and grant for research & development of oncology drugs and treatment is also boosting the
growth of chemotherapy market. The reimbursements provided in various countries is also a major factor propelling the market growth. Apart from that,
people are now aware of deadly cancer diseases and hence are willing to spend for the treatment of cancer. Thus, increasing expenditure on
healthcare is also one of the major factors driving the growth of global chemotherapy market. Moreover, governments in various economies are also
taking initiatives to provide best healthcare services to the people. This has led to establishment of various cancer research and treatment centers. The
increase in healthcare centers and cancer treatment options is further expected to boost the growth of global chemotherapy market. After an early
detection of cancer, most of the oncologists prefer chemotherapy treatment to avoid further multiplication of cancerous cells. This also prevents the
further growth of tumors cells, thereby fueling demand for chemotherapy treatment around the world. However, the global chemotherapy market also
faces some challenges. It is a time-consuming treatment and takes several months to show the symptoms of improvement. This might pose as a threat
for the market growth. Also, the side-effects associated with chemotherapy is anticipated to restrain overall market growth.
The global chemotherapy market is segmented based on drugs, type, indication, route of administration, end-user and region. Based on type, the
market is segmented into alkylating agents, nitrosoureas, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors,
corticosteroids and others. The alkylating agents holds dominance in the global chemotherapy market and is expected to undergo rapid growth during
the forecast period as they stop the growth of tumor by crosslinking guanine nucleobases in DNA double-helix strands, directly attacking DNA. This is
the most effective way of treating cancer. Based on route of administration, the global oncology drugs market is segmented into intravenous, orally,
transdermal, intraperitoneal, intrapleural, intrathecal, intravesical and others. The intravenous segment accounted for largest market share in 2019.
However, the oral segment is expected to grow at the highest CAGR during the forecast period as they come in different forms and can be taken even
at home. Also, the continuous launch of new oral chemotherapy drugs is propelling the growth of this segment.
Major players operating in the global chemotherapy market include Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca,
Bristol-Myers Squibb, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Fresenius Kabi AG, Novartis AG, Sanofi, Merck & Co., Pfizer
Inc., Roche Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Tarveda Therapeutics, Bayer AG,Johnson & Johnson Services Inc. and
Celltrion Inc., etc. The companies are investing on development of novel chemotherapy drugs, which is providing great opportunity for the market
growth. Moreover, companies are doing partnership with other pharma companies to bring into novel products for chemotherapy treatment.
“Regionally, North America dominates the global chemotherapy market as it has world class cancer treatment facilities. The region is also witnessing
rising number of cancer patients, which is fueling the market. However, Europe is expected to undergo highest CAGR during the forecast period on
account of supportive government initiatives to develop novel drug products for treatment of cancer. Additionally, countries like Italy and France have
some of the world’s best medical research centers and hospitals,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.

22. 22
Sample Data - Snapshot
Global Chemotherapy Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Chemotherapy Market Share, By Drugs, By Value, 2015–2025F
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Alone Combination
United States Chemotherapy Market Share, By Type, By Value, 2015–2025F
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
12%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
13%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Alkylating Agents Nitrosoureas Antimetabolites Anti-tumor Antibiotics

23. 23
Report Ordering
Report Name: GLOBAL CHEMOTHERAPY MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
To View Sample OR Purchase Report
License Type Price
Single User License $4450
Multi-User License $5450
Custom Research License $9450

24. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By
Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
• Global Infectious Disease Testing Market By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology
(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Others), By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular
fever, Coronavirus, Others), By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes,
Other), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com